Accordingly, we found a higher expression of the stem cell marker CD133 [35, 36] and of the self-renewal marker Bmi1 [37] in tumor xenografts sections derived from CTCDOs (Fig. 4B-C), while the differentiation marker CK20 was expressed at lower levels as compared to XDOs-derived xenografts. Here, PROM1 is linked to neoplasm.